Ardent Health (ARDT) EBIAT (2023 - 2026)

Ardent Health has reported EBIAT for 4 years, with the latest figure at $39.8 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT fell 3.7% year-over-year to $39.8 million; the trailing twelve-month figure through Mar 2026 stood at $163.6 million (down 34.92% YoY), and the FY2025 full-year result was $230.1 million, down 23.21% from the prior year.
• EBIAT for Q1 2026 stood at $39.8 million, down from $74.3 million in the prior quarter.
• The five-year high for EBIAT was $140.9 million in Q4 2024, with the low at -$23.5 million in Q3 2025.
• Average EBIAT over 4 years is $41.0 million, with a median of $36.5 million recorded in 2023.
• Year-over-year, EBIAT soared 3492.51% in 2024 and slumped 189.2% in 2025.
• Tracing ARDT's EBIAT over 4 years: stood at -$4.2 million in 2023, then soared by 3492.51% to $140.9 million in 2024, then slumped by 47.29% to $74.3 million in 2025, then slumped by 46.34% to $39.8 million in 2026.
• The last three EBIAT figures came in at $39.8 million (Q1 2026), $74.3 million (Q4 2025), and -$23.5 million (Q3 2025), per Business Quant data.

Peer Comparison